The autophagy inhibitor chloroquine overcomes the innate resistance of wild-type EGFR non-small-cell lung cancer cells to erlotinib

Research output: Contribution to journalArticlepeer-review

86 Scopus citations

Fingerprint

Dive into the research topics of 'The autophagy inhibitor chloroquine overcomes the innate resistance of wild-type EGFR non-small-cell lung cancer cells to erlotinib'. Together they form a unique fingerprint.

Medicine & Life Sciences